ITI Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by ITI Asset Management Limited

3Y Returns (CAGR)
20.35%
Expense Ratio
0.92%

as of 01/08/2026

AUM
₹18.82 Cr

Qtr End: Jun 26

NAV
₹20.013

as of 02/09/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M10.46%48.88%10.91%
6M17.66%38.44%13.94%
1Y13.96%13.96%13.25%
3Y74.34%20.35%14.31%
5YN/AN/AN/A
Scheme Details
Launch Date
18/10/2021
Fund Age
4.9 years
Minimum Investment
₹5,000
Fund House
ITI Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions